178 related articles for article (PubMed ID: 17507346)
1. Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma.
Fukino K; Shen L; Patocs A; Mutter GL; Eng C
JAMA; 2007 May; 297(19):2103-11. PubMed ID: 17507346
[TBL] [Abstract][Full Text] [Related]
2. Breast-cancer stromal cells with TP53 mutations and nodal metastases.
Patocs A; Zhang L; Xu Y; Weber F; Caldes T; Mutter GL; Platzer P; Eng C
N Engl J Med; 2007 Dec; 357(25):2543-51. PubMed ID: 18094375
[TBL] [Abstract][Full Text] [Related]
3. Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma.
Weber F; Xu Y; Zhang L; Patocs A; Shen L; Platzer P; Eng C
JAMA; 2007 Jan; 297(2):187-95. PubMed ID: 17213402
[TBL] [Abstract][Full Text] [Related]
4. Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation.
Weber F; Shen L; Fukino K; Patocs A; Mutter GL; Caldes T; Eng C
Am J Hum Genet; 2006 Jun; 78(6):961-72. PubMed ID: 16685647
[TBL] [Abstract][Full Text] [Related]
5. Genomic instability in the breast microenvironment? A critical evaluation of the evidence.
Holliday C; Rummel S; Hooke JA; Shriver CD; Ellsworth DL; Ellsworth RE
Expert Rev Mol Diagn; 2009 Oct; 9(7):667-78. PubMed ID: 19817552
[TBL] [Abstract][Full Text] [Related]
6. Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets.
Fukino K; Shen L; Matsumoto S; Morrison CD; Mutter GL; Eng C
Cancer Res; 2004 Oct; 64(20):7231-6. PubMed ID: 15492239
[TBL] [Abstract][Full Text] [Related]
7. Genomic alterations associated with early stages of breast tumor metastasis.
Ellsworth RE; Ellsworth DL; Patney HL; Deyarmin B; Hooke JA; Love B; Shriver CD
Ann Surg Oncol; 2008 Jul; 15(7):1989-95. PubMed ID: 18401664
[TBL] [Abstract][Full Text] [Related]
8. Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma.
Tsukamoto K; Ito N; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
Cancer; 1998 Jan; 82(2):317-22. PubMed ID: 9445188
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity and allelic imbalance in apocrine adenosis of the breast.
Selim AG; Ryan A; El-Ayat GA; Wells CA
Cancer Detect Prev; 2001; 25(3):262-7. PubMed ID: 11425268
[TBL] [Abstract][Full Text] [Related]
10. Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers.
Nagahata T; Hirano A; Utada Y; Tsuchiya S; Takahashi K; Tada T; Makita M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
Breast Cancer; 2002; 9(3):208-15. PubMed ID: 12185331
[TBL] [Abstract][Full Text] [Related]
11. Genomic patterns of allelic imbalance in disease free tissue adjacent to primary breast carcinomas.
Ellsworth DL; Ellsworth RE; Love B; Deyarmin B; Lubert SM; Mittal V; Shriver CD
Breast Cancer Res Treat; 2004 Nov; 88(2):131-9. PubMed ID: 15564796
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas.
Larson PS; de las Morenas A; Bennett SR; Cupples LA; Rosenberg CL
Am J Pathol; 2002 Jul; 161(1):283-90. PubMed ID: 12107113
[TBL] [Abstract][Full Text] [Related]
13. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors.
Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Markopoulos C; Gogas J; Kittas C
Cancer; 2002 May; 94(9):2454-65. PubMed ID: 12015771
[TBL] [Abstract][Full Text] [Related]
14. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C
Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability and loss of heterozygosity in breast cancer.
Yee CJ; Roodi N; Verrier CS; Parl FF
Cancer Res; 1994 Apr; 54(7):1641-4. PubMed ID: 8137273
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal region 15q21.1 is a frequent target of allelic imbalance in advanced breast carcinomas.
Rhiem K; Klein A; Münch M; Kreutzfeld R; Ramser J; Wardelmann E; Schackert G; Von Deimling A; Wiestler OD; Schmutzler RK
Int J Cancer; 2003 Aug; 106(1):74-7. PubMed ID: 12794759
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity in thyroid hormone receptor beta in invasive breast cancer.
Ling Y; Li Q; Yang H; Wang Y; Tang F; Kang H; Wang Y
Tumori; 2015; 101(5):572-7. PubMed ID: 26350179
[TBL] [Abstract][Full Text] [Related]
18. [Early loss of heterozygosity on chromosome arm 16q in flat epithelial atypia of the breast. Detection by microsatellite analyses].
Schmidt H; Dahrenmöller C; Agelepoulos K; Hungermann D; Böcker W
Pathologe; 2008 Nov; 29 Suppl 2():328-32. PubMed ID: 18807038
[TBL] [Abstract][Full Text] [Related]
19. Amplification of HER2 is a marker for global genomic instability.
Ellsworth RE; Ellsworth DL; Patney HL; Deyarmin B; Love B; Hooke JA; Shriver CD
BMC Cancer; 2008 Oct; 8():297. PubMed ID: 18854030
[TBL] [Abstract][Full Text] [Related]
20. [Frequent allelic losses in tumor-associated stromal cells and tumor epitelium of prostate cancer].
Kekeeva TV; Popova OP; Shegaĭ PV; Zavalishina LE; Andreeva IuIu; Zaletaev DV; Nemtsova MV
Mol Biol (Mosk); 2008; 42(1):96-101. PubMed ID: 18389625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
